Research That Moves Melanoma Care Forward
A decade ago, a diagnosis of advanced melanoma carried a very different weight than it does today. That shift didn't happen by accident — it happened because researchers kept asking uncomfortable questions, ran trials that sometimes failed, and refused to accept "this is as good as it gets." That same restlessness drives the work you'll find here.
Where the Work Is Concentrated
Our current studies span the full arc from bench to bedside: early detection tools that catch atypical lesions before they progress, biomarker panels that help predict who will respond to immunotherapy, and clinical trials testing combination regimens in both adjuvant and metastatic settings. Translational research sits at the center of it all — taking findings from tumor biology and turning them into decisions clinicians can actually use.
- Multi-center clinical trials across melanoma stages
- Molecular and immune biomarker discovery
- Diagnostic imaging and digital pathology advances
- Long-term outcome and quality-of-life data collection
Publications and Shared Knowledge
Results only matter if they reach the people who can act on them. That's why findings from our studies are published in peer-reviewed journals and shared openly with the broader oncology community, including negative or inconclusive results — because knowing what doesn't work is often just as valuable as knowing what does.
Explore or Collaborate
Whether you're a clinician, a researcher, or simply someone trying to understand the science behind modern melanoma treatment, there's a way to engage with this work. Get in touch to learn more about current trials, data access, or partnership opportunities.